In this issue:
Efficacy of obe-cel
CD19 CAR-T cell therapy in autoimmune diseases
Autologous anti-CD7 CAR-T cells plus protein expression blocker
Anti-CD123+ CAR-T cells in R/R AML
FT596 plus rituximab
Safety and activity of CTX130
Tolerability of GCC19CART
B7-H3-specific CAR T cells at varying dosages
EBV-CTL plus GC
Soluble BCMA and anti-BCMA therapies
Please login below to download this issue (PDF)